Clinical Trial: In-use Tolerance and Efficacy Study Under Dermatological and Ophthalmological Controls - Face Cream, RV4983A - LA3365

U.S., Oct. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07208227) titled 'In-use Tolerance and Efficacy Study Under Dermatological and Ophthalmological Controls - Face Cream, RV4983A - LA3365' on Sept. 15.

Brief Summary: Tolerance and efficacy study of an anti aging cream on 44 subjects aged between 45 and 65 years, with sensitive skin and deep wrinkles. This study is conducted as a national, monocentric, non-randomized open trial.

Planning of the visits:

* Visit 1: Inclusion (Day 1)

* Visit 2: Intermediate visit (Day 29), a window of +48 hours is allowed

* Visit 3: End of study (Day 57), a window of +72 hours is allowed The maximum duration of participation for a subject is 60 days.

Study Start Date:...